UCB - Pre Tax Profit

Stock Price
252.30
Daily Change
3.90 1.57%
Monthly
-0.39%
Yearly
38.97%
Q1 Forecast
269.39

UCB reported EUR789M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Alcon AG USD 283M 84M Sep/2025
Amarin USD -8.12M 5.34M Sep/2025
argenx SE USD 386.05M 99.15M Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Bayer EUR -1.16B 735M Sep/2025
Galapagos EUR -221.49M 117.07M Sep/2025
Genmab DKK 482M 59M Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lonza CHF 624M 197M Dec/2024
Merck EUR 1.29B 458.1M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Orion EUR 327M 206.6M Dec/2025
Recordati EUR 144.95M 25.46M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025